Travel Medicine and Infectious Disease
Volume 8, Issue 4 , Pages 263-268 , July 2010

Time to put out the lights on sleeping sickness?

  • Camus Nimmo

      Affiliations

    • Corresponding Author InformationPresent address: 5 Whitehouse Terrace, Edinburgh EH9 2EU, UK. Tel.: +44 (0) 7841 758191.

Received 30 November 2009 ,Revised 29 April 2010 ,Accepted 5 May 2010.

References 

  1. WHO list of neglected tropical diseases. [cited 2010 Apr 28]. Available from http://www.who.int/neglected_diseases/diseases/en
  2. Simarro P, Jannin J, Cattand P. Eliminating human African trypanosomiasis: where do we stand and what comes next?. PLoS Med. 2008 Feb;5(2):174–180
  3. Weekly Epidemiological Record. 2006 Feb 24;81:69–80
  4. Jannin J, Louis FJ, Lucas P, Simarro PP. Control of human African trypanosomiasis: back to square one (in French). Med Trop (Mars). 2001;61(4–5):437–440
  5. WHO report on Global surveillance of epidemic-prone infectious diseases. p95–106 [cited 2010 Apr 28]. Available from http://www.who.int/csr/resources/publications/surveillance/a_tryps.pdf
  6. Koffi M, De Meeûs T, Bucheton B, Solano P, Camara M, Kaba D, et al. Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc Natl Acad Sci USA. 2009 Jan 6;106(1):209–214
  7. MacLeod A, Tait A, Turner CM. The population genetics of Trypanosoma brucei and the origin of human infectivity. Philos Trans R Soc Lond B Biol Sci. 2001 Jul 29;356(1411):1035–1044
  8. Solano P, Ravel S, de Meeûs T. How can tsetse population genetics contribute to African trypanosomiasis control?. Trends Parasitol. 2010 May;26(5):255–263
  9. Steverding D. The history of African trypanosomiasis. Parasit Vectors. 2008;1:3
  10. Courtin F, Sidibé I, Rouamba J, Jamonneau V, Gouro A, Solano P. Population growth and global warming: impacts on tsetse and trypanosomoses in West Africa (in French). Parasite. 2009 Mar;16(1):3–10
  11. de Raadt P. The history of sleeping sickness. Fourth International cours on African trypanosomoses. [cited 2010 Apr 28]. Available from: http://www.who.int/trypanosomiasis_african/country/history/en/index.html2005 Oct 11-28;
  12. Hoppe KA. Lords of the fly: colonial visions and revisions of African sleeping-sickness environments on Ugandan Lake Victoria, 1906-61. Africa. 1997;67(1):86–105
  13. Vreysen MJ, Saleh KM, Ali MY, Abdulla AM, Zhu ZR, Juma KG, et al. Glossina austeni eradicated on the island of Unguja, Zanzibar, using the sterile insect technique. J Econ Entomol. 2000 Feb;93(1):123–135
  14. Kabayo JP. Aiming to eliminate tsetse from Africa. Trends Parasitol. 2002 Nov;18(11):473–475
  15. PATTEC Newsletter. 2002 Mar;Available from http://www.africa-union.org/Structure_of_the_Commission/Pattec/Maiden%20Edition-PATTEC%20newsleter–3.pdf
  16. PATTEC Plan of Action. 2001 Jun;Available from http://www.africa-union.org/Structure_of_the_Commission/Pattec/PATTECAction_Plan_English.pdf
  17. The PATTEC . Initiative since Inception: 2000-2009. [cited 2010 Apr 28]. Available from http://www.pattec.org/reports/PATTEC_Key_Milestones.pdf
  18. Maudlin I. African trypanosomiasis – centennial review. Ann Trop Med Parasitol. 2006;100:679–701
  19. African Union . Statement from the Commission of the African Union to the AHP/DFID special workshop on tsetse control – the next 100 years. 2002 Sept 9–10;Edinburgh, UK [cited 2010 Apr 28]. Available from http://www.africa-union.org/Structure_of_the_Commission/Pattec/Statement%20by%20the%20Commission%20V2.pdf
  20. Report of a WHO Informal Consultation on Sustainable Control of Human African Trypanosomiasis . [cited 2010 Apr 28]. Available from http://whqlibdoc.who.int/hq/2007/WHO_CDS_NTD_IDM_2007.6_eng.pdf
  21. Samarasekera U. Margaret Chan’s vision for the WHO. Lancet. 2007;369:1915–1916
  22. Deborggraeve S, Claes F, Laurent T, Mertens P, Leclipteux T, Dujardin JC, et al. Molecular dipstick test for diagnosis of sleeping sickness. J Clin Microbiol. 2006;44:2884–2889
  23. Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud ME, Checchi F. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes. Trans R Soc Trop Med Hyg. 2009 Mar;103(3):280–290
  24. Blum J, Nkunku S, Burri C. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Trop Med Int Health. 2001;6:390–400
  25. Press release . Immtech focusing on new infectious disease programs following discontinuation of development of pafuramidine. Available from http://www.immtechpharma.com/documents/news_022208.pdfReleased 2008 Feb 22;[cited 2010 Apr 28]
  26. Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, et al. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet. 2009 Jul 4;374(9683):56–64
  27. WHO model list of essential medicines. 16th ed. Released 2009 Mar;Available from http://www.who.int/medicines/publications/essentialmedicines/en/[cited 2010 Apr 28]
  28. Courtin D, Berthier D, Thevenon S, Dayo GK, Garcia A, Boucheton B. Host genetics in African trypanosomiasis. Infect Genet Evol. 2008 May;8(3):229–238
  29. Garcia A, Courtin D, Solano P, Koffi M, Jamonneau V. Human African trypanosomiasis: connecting parasite and host genetics. Trends Parasitol. 2006 Sep;22(9):405–409
  30. Kgori PM, Modo S, Torr SJ. The use of aerial spraying to eliminate tsetse from the Okavango Delta of Botswana. Acta Trop. 2006 Oct;99(2–3):184–199
  31. Hargrove JW, Omolo S, Msalilwa JS, Fox B. Insecticide-treated cattle for tsetse control: the power and the problems. Med Vet Entomol. 2000 Jun;14(2):123–130
  32. Aksoy S, Berriman M, Hall N, Hattori M, Hide W, Lehane MJ. A case for a Glossina genome project. Trend Parasitol. 2005;21:107–111
  33. Rowlands GJ, Leak SG, Mulatu W, Nagda SM, Wilson A, d’Ieteren GD. Use of deltamethrin ‘pour-on’ insecticide for the control of cattle trypanosomosis in the presence of high tsetse invasion. Med Vet Entomol. 2001 Mar;15(1):87–96
  34. Okiria R, Okuna NM, Magona JW, Mayende JS. Sustainability of tsetse control by subsequent treatment of 10% of a previously treated Ugandan cattle population with 1% w/v deltamethrin. Trop Anim Health Prod. 2002 Mar;34(2):105–114
  35. Rowland M, Durrani N, Kenward M, Mohammed N, Urahman H, Hewitt S. Control of malaria in Pakistan by applying deltamethrin insecticide to cattle: a community-randomised trial. Lancet. 2001 Jun 9;357(9271):1837–1841
  36. Kagbadouno M, Camara M, Bouyer J, Hervouet JP, Courtin F, Jamonneau V, et al. Tsetse elimination: its interest and feasibility in the historical sleeping sickness focus of Loos islands, Guinea. Parasite. 2009 Mar;16(1):29–35

PII: S1477-8939(10)00066-9

doi: 10.1016/j.tmaid.2010.05.001

Travel Medicine and Infectious Disease
Volume 8, Issue 4 , Pages 263-268 , July 2010

Article Tools

* Image Usage & Resolution